NSF grant aiding startup's work to treat COVID-19, stop future viral pandemics

(Purdue University) A Purdue University-affiliated startup is receiving national support to pursue a strategy to treat severe COVID-19 cases and possible future outbreaks involving other viruses. Akanocure Pharmaceuticals Inc. has received a $256,000 Phase I research grant from the National Science Foundation.
Source: EurekAlert! - Infectious and Emerging Diseases - Category: Infectious Diseases Source Type: news